| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.06 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.06 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.06 |